Receiving a diagnosis of actinomycosis can be a surprising and confusing experience. This rare bacterial infection often develops slowly, creating painful lumps or abscesses that may be mistaken for other conditions, such as tumors, before a correct diagnosis is made. Whether it affects the jaw, chest, or abdomen, the condition can be physically uncomfortable and emotionally draining due to the presence of draining sores or persistent swelling. While the infection is chronic and can cause significant tissue damage if ignored, the outlook is very positive with appropriate care. 

Treatment is essential to eradicate the bacteria completely and prevent the infection from spreading to bones or other organs. Because actinomyces bacteria create hard, fibrous barriers around themselves, clearing the infection takes time and persistence. Treatment plans are highly individualized; a simple case in the jaw might require a shorter course of medication, whereas deep infections in the chest or abdomen often necessitate aggressive therapy. Successful management relies on a combination of long-term medication and, in some cases, surgical drainage (National Organization for Rare Disorders, 2019). 

Overview of treatment options for Actinomycosis 

The gold standard for treating actinomycosis is high-dose, long-term antibiotic therapy. Unlike typical bacterial infections that resolve in a week or two, actinomycosis requires a sustained medical attack to penetrate the dense tissue and “sulfur granules” characteristic of the disease. 

The primary goal is to kill the bacteria and allow the body’s tissues to heal. While antibiotics are the curative agent, surgical procedures are often performed alongside medication to drain large abscesses or remove damaged tissue. This combined approach makes the medication more effective by reducing the bacterial load. Treatment typically starts with intravenous (IV) medication in a hospital setting and transitions to oral pills for several months. 

Medications used for Actinomycosis 

The first-line defense against actinomycosis is the penicillin class of antibiotics. For severe infections, doctors typically begin with intravenous penicillin G. This is administered to deliver high concentrations of the drug rapidly throughout the body. Once the patient stabilizes and symptoms begin to improve, therapy switches to oral penicillin V. Clinical experience suggests that maintaining this oral regimen for several months, often six to twelve, is crucial to prevent relapse. 

For patients who are allergic to penicillin, safe and effective alternatives are available. Tetracyclines, such as doxycycline, are frequently prescribed. Other options include macrolides (like erythromycin) or clindamycin. These medications are effective second-line choices that cover the specific bacteria responsible for the infection. 

Patients can generally expect to see an improvement in pain and a reduction in drainage within a few weeks of starting high-dose therapy. However, the hardness of the infected area (fibrosis) may take much longer to resolve. It is vital to continue medication long after the visible symptoms disappear (MedlinePlus, 2022). 

How these medications work 

Penicillins work by attacking the structural integrity of the bacteria. They inhibit the synthesis of the bacterial cell wall, the protective outer layer that holds the bacterium together. Without a strong wall, the bacteria become unstable and burst, stopping the infection from growing. 

Alternative medications like tetracyclines and macrolides work by inhibiting protein synthesis. Bacteria need to produce specific proteins to grow, repair themselves, and replicate. By blocking the machinery inside the cell that builds these proteins, the medication effectively starves the bacteria and stops them from multiplying. This halts the spread of the infection and gives the body’s immune system a chance to eliminate the remaining pathogens (Mayo Clinic, 2022). 

Side effects and safety considerations 

Because treatment for actinomycosis is prolonged, managing side effects is a key part of the process. Antibiotics, like penicillin, often cause GI upset (nausea, vomiting, diarrhea). Prolonged use raises the risk of secondary infections, such as yeast infections (thrush) or severe C. diff diarrhea. 

Penicillin allergies range from mild rash to severe anaphylaxis, necessitating a careful allergy history. Doxycycline users must be warned about sun sensitivity. Monitor for liver or kidney strain during long-term treatment. Patients should seek immediate care for difficulty breathing, severe watery diarrhea, or a rapidly spreading rash. 

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care. 

References 

  1. Mayo Clinic. https://www.mayoclinic.org 
  1. MedlinePlus. https://medlineplus.gov 
  1. National Organization for Rare Disorders. https://rarediseases.org 
  1. Merck Manuals. https://www.merckmanuals.com 

Medications for Actinomycosis

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Actinomycosis.

Found 3 Approved Drugs for Actinomycosis

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Ultramicrosize

Brand Names
Grisofulvin, Microsize, Fulvicin

Ultramicrosize

Brand Names
Grisofulvin, Microsize, Fulvicin
Ultramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis,Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. NOTE: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. Griseofulvin is not effective in the following: bacterial infections, candidiasis (moniliasis), histoplasmosis, actinomycosis, sporotrichosis, chromoblastomycosis, coccidioidomycosis, North American blastomycosis, cryptococcosis (torulosis), tinea versicolor and nocardiosis.

Demeclocycline

Generic Name
Demeclocycline

Demeclocycline

Generic Name
Demeclocycline
Demeclocycline hydrochloride tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae; Respiratory tract infections caused by Mycoplasma pneumoniae Lymphogranuloma venereum due to Chlamydia trachomatis Psittacosis (Ornithosis) due to Chlamydia psittaci Trachoma due to Chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence Inclusion conjunctivitis caused by Chlamydia trachomatis Nongonococcal urethritis in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis Relapsing fever due to Borrelia recurrentis Chancroid caused by Haemophilus ducreyi Plague due to Yersinia pestis Tularemia due to Francisella tularensis Cholera caused by Vibrio cholerae Campylobacter fetus infections cause by Campylobacter fetus Brucellosis due to Brucella species (in conjunction with streptomycin); Bartonellosis due to Bartonella bacilliformis Granuloma inguinale caused by Calymmatobacterium granulomatis Demeclocycline hydrochloride tablets are indicated for treatment of infections by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli Enterobacter aerogenes Shigella species Acinetobacter species Respiratory tract infections caused by Haemophilus influenzae Respiratory tract and urinary tract infections caused by Klebsiella species Demeclocycline hydrochloride tablets are indicated for treatment of infections caused by the following gram-positive microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory infections caused by Streptococcus pneumoniae Skin and skin structure infections caused by Staphylococcus aureus. (Note: Tetracyclines, including demeclocycline, are not the drugs of choice in the treatment of any type of staphylococcal infection). When penicillin is contraindicated, tetracyclines, including demeclocycline hydrochloride, are alternative drugs in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae, and for the treatment of other uncomplicated gonococcal infections Infections in women caused by Neisseria gonorrhoeae Syphilis caused by Treponema pallidum subspecies pallidum Yaws caused by Treponema pallidum subspecies pertenue Listeriosis due to Listeria monocytogenes Anthrax due to Bacillus anthracis Vincent’s infection caused by Fusobacterium fusiforme Actinomycosis caused by Actinomyces israelii Clostridial diseases caused by Clostridium species In acute intestinal amebiasis, demeclocycline hydrochloride may be a useful adjunct to amebicides. In severe acne, demeclocycline hydrochloride may be a useful adjunctive therapy. To reduce the development of drug-resistant bacteria and maintain the effectiveness of demeclocycline hydrochloride tablets and other antibacterial drugs, demeclocycline hydrochloride tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances